International Journal of Infection

Published by: Kowsar

Comparing Hydroxychloroquine and Pyrimethamine With Sulfadoxine-Pyrimethamine to Treat Plasmodium berghei Infection in Mice

Mohammad Reza Vafaei 1 , Somayeh Jahani 2 , Hamed Kalani 1 and Nader Pestehchian 1 , *
Authors Information
1 Department of Parasitology and Mycology, Tropical Medicine Research Center, School of Medicine and Infectious Diseases, Isfahan University of Medical Sciences, Isfahan, IR Iran
2 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • International Journal of Infection: April 2017, 4 (2); e41117
  • Published Online: August 31, 2016
  • Article Type: Research Article
  • Received: August 4, 2016
  • Accepted: August 13, 2016
  • DOI: 10.5812/iji.41117

To Cite: Vafaei M R, Jahani S, Kalani H, Pestehchian N. Comparing Hydroxychloroquine and Pyrimethamine With Sulfadoxine-Pyrimethamine to Treat Plasmodium berghei Infection in Mice, Int J Infect. 2017 ; 4(2):e41117. doi: 10.5812/iji.41117.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Hansen DS. Inflammatory responses associated with the induction of cerebral malaria: lessons from experimental murine models. PLoS Pathog. 2012; 8(12): 1003045[DOI][PubMed]
  • 2. Athuman M, Kabanywanyi AM, Rohwer AC. Intermittent preventive antimalarial treatment for children with anaemia. Cochrane Database Syst Rev. 2015; 1: 10767[DOI][PubMed]
  • 3. World malaria report 2008. 2008;
  • 4. Global report on antimalarial drug efficacy and drug resistance 2000-2010. 2010;
  • 5. Krishna Ch V, Rao PV, Das GC, Kumar VS. Acute renal failure in falciparum malaria: clinical characteristics, demonstration of oxidative stress, and prognostication. Saudi J Kidney Dis Transpl. 2012; 23(2): 296-300[PubMed]
  • 6. Engwerda CR, Beattie L, Amante FH. The importance of the spleen in malaria. Trends Parasitol. 2005; 21(2): 75-80[DOI][PubMed]
  • 7. Basco LK. Field application of in vitro assays for the sensitivity of human malaria parasites to antimalarial drugs. 2007;
  • 8. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations: informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization. 2008;
  • 9. Reyburn H. New WHO guidelines for the treatment of malaria. BMJ. 2010; 340: 2637[DOI][PubMed]
  • 10. Jambou R, El-Assaad F, Combes V, Grau GE. In vitro culture of Plasmodium berghei-ANKA maintains infectivity of mouse erythrocytes inducing cerebral malaria. Malaria J. 2011; 10(1): 1-5[DOI]
  • 11. Ajibade A, Adenowo T, Akintunde O, Fakunle P, Oyewo O, Ashamu E. Suppression of exploration and locomotion in adult Wistar rats following quinine administration. J Neurosci Behav Health. 2011; 3: 32-7
  • 12. Parapini S, Olliaro P, Navaratnam V, Taramelli D, Basilico N. Stability of the antimalarial drug dihydroartemisinin under physiologically relevant conditions: implications for clinical treatment and pharmacokinetic and in vitro assays. Antimicrob Agents Chemother. 2015; 59(7): 4046-52[DOI]
  • 13. Andayi WA, Egan TJ, Gut J, Rosenthal PJ, Chibale K. Synthesis, Antiplasmodial Activity, and β-Hematin Inhibition of Hydroxypyridone-Chloroquine Hybrids. Acs Medicinal Chem Lett. 2013; 4(7): 642-6[DOI]
  • 14. Takala-Harrison S, Laufer MK. Antimalarial drug resistance in Africa: key lessons for the future. Ann N Y Acad Sci. 2015; 1342: 62-7[DOI][PubMed]
  • 15. Borlon C, Russell B, Sriprawat K, Suwanarusk R, Erhart A, Renia L. Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture. Int J Parasitol. 2012; 42(2): 155-60[DOI]
  • 16. Ryley JF, Peters W. The antimalarial activity of some quinolone esters. Ann Trop Med Parasitol. 1970; 64(2): 209-22[PubMed]
  • 17. The Africa malaria report. 2003;
  • 18. Cibulskis RE, Aregawi M, Williams R, Otten M, Dye C. Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods. PLoS Med. 2011; 8(12): 1001142[DOI][PubMed]
  • 19. Kumar A, Valecha N, Jain T, Dash AP. Burden of malaria in India: retrospective and prospective view. Am J Trop Med Hyg. 2007; 77(6 Suppl): 69-78[PubMed]
  • 20. Sharma VP. Battling the malaria iceberg with chloroquine in India. Malar J. 2007; 6: 105[DOI][PubMed]
  • 21. Bloland P, Kazembe P, Oloo A, Himonga B, Barat L, Ruebush T. Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub‐Saharan Africa. Tropical Med Int Health. 1998; 3(7): 543-52[DOI]
  • 22. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, et al. Averting a malaria disaster. Lancet. 1999; 353(9168): 1965-7[PubMed]
  • 23. White NJ. Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia. 1999; 41(1-3): 301-8[PubMed]
  • 24. McIntosh HM, Jones KL. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malaria. Cochrane Database Syst Rev. 2005; (4): 386[DOI][PubMed]
  • 25. Sezi C, Nevil C, Ochen K, Munafu C, Bekobita D. The response of Plasmodium falciparum to 4-aminoquinolines and pyrimethamine/sulfadoxine at six sites scattered throughout Uganda. Uganda Med J. 1991; 8: 33-46
  • 26. Staedke SG, Kamya MR, Dorsey G, Gasasira A, Ndeezi G, Charlebois ED. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet. 2001; 358(9279): 368-74[DOI]
  • 27. Falajiki Y, Akinola O, Abiodun O, Happi C, Sowunmi A, Gbotosho G. Amodiaquine-Ciprofloxacin: a potential combination therapy against drug resistant malaria. Parasitol. 2015; 142(6): 849-54[DOI]
  • 28. Visser BJ, Wieten RW, Kroon D, Nagel IM, Bélard S, van Vugt M. Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review. Malaria J. 2014; 13(1): 1-18[DOI]
  • 29. Gbotosho GO, Happi CT, Woranola O, Abiodun OO, Sowunmi A, Oduola AM. Interaction between ciprofloxacin and chloroquine in mice infected with chloroquine resistant Plasmodium berghei: interaction between ciprofloxacin and chloroqune. Parasitol Res. 2012; 110(2): 895-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments